Medicamen Biotech Limited MEDICAMEQ.NS Stock
Medicamen Biotech Limited Price Chart
Medicamen Biotech Limited MEDICAMEQ.NS Financial and Trading Overview
Medicamen Biotech Limited stock price | 430.55 INR |
Previous Close | 664.5 INR |
Open | 668.05 INR |
Bid | 691 INR x N/A |
Ask | 695 INR x N/A |
Day's Range | 665.15 - 711.05 INR |
52 Week Range | 557.2 - 1225 INR |
Volume | 29.36K INR |
Avg. Volume | 12.22K INR |
Market Cap | 8.76B INR |
Beta (5Y Monthly) | 1.389383 |
PE Ratio (TTM) | 58.208576 |
EPS (TTM) | 9.05 INR |
Forward Dividend & Yield | 1 (0.14%) |
Ex-Dividend Date | September 19, 2022 |
1y Target Est | N/A |
MEDICAMEQ.NS Valuation Measures
Enterprise Value | 8.28B INR |
Trailing P/E | 58.208576 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 6.2156506 |
Price/Book (mrq) | 4.4507174 |
Enterprise Value/Revenue | 5.881 |
Enterprise Value/EBITDA | 34.702 |
Trading Information
Medicamen Biotech Limited Stock Price History
Beta (5Y Monthly) | 1.389383 |
52-Week Change | 8.91% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1225 INR |
52 Week Low | 557.2 INR |
50-Day Moving Average | 693.59 INR |
200-Day Moving Average | 802.12 INR |
MEDICAMEQ.NS Share Statistics
Avg. Volume (3 month) | 12.22K INR |
Avg. Daily Volume (10-Days) | 7K INR |
Shares Outstanding | 12.65M |
Float | 5M |
Short Ratio | N/A |
% Held by Insiders | 59.84% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1 |
Trailing Annual Dividend Yield | 0.15% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.0846 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 10.53% |
Operating Margin (ttm) | 12.42% |
Gross Margin | 48.82% |
EBITDA Margin | 16.94% |
Management Effectiveness
Return on Assets (ttm) | 4.33% |
Return on Equity (ttm) | 8.66% |
Income Statement
Revenue (ttm) | 1.41B INR |
Revenue Per Share (ttm) | 112.17 INR |
Quarterly Revenue Growth (yoy) | 69.89% |
Gross Profit (ttm) | 712.36M INR |
EBITDA | 238.72M INR |
Net Income Avi to Common (ttm) | 148.44M INR |
Diluted EPS (ttm) | 11.89 |
Quarterly Earnings Growth (yoy) | 37.29% |
Balance Sheet
Total Cash (mrq) | 207.79M INR |
Total Cash Per Share (mrq) | 16.71 INR |
Total Debt (mrq) | 241.83M INR |
Total Debt/Equity (mrq) | 12.5 INR |
Current Ratio (mrq) | 1.978 |
Book Value Per Share (mrq) | 155.503 |
Cash Flow Statement
Operating Cash Flow (ttm) | -62928000 INR |
Levered Free Cash Flow (ttm) | -71991840 INR |
Profile of Medicamen Biotech Limited
Country | India |
State | N/A |
City | New Delhi |
Address | 1506, Chiranjiv Tower |
ZIP | 110019 |
Phone | 91 11 4758 9500 |
Website | https://medicamen.com/ |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Medicamen Biotech Limited researches, develops, manufactures, sells, and distributes pharmaceutical formulations and APIs in India. It offers a range of products, including tablets, such as non-beta lactum tablets; capsules comprising beta and non-beta lactum capsules; liquid and dry syrups; and ointments and creams. The company also provides lyohilized/dry powder injections, and oral solid and liquid products. Its products are used in various therapeutic areas, such as gastrointestinal, pain management, anti-infectives, pediatrics, dermatology, gynecology and rheumatology, diabetology, cardiology, oncology, and the central nervous system. The company was incorporated in 1993 and is based in New Delhi, India.
Q&A For Medicamen Biotech Limited Stock
What is a current MEDICAMEQ.NS stock price?
Medicamen Biotech Limited MEDICAMEQ.NS stock price today per share is 430.55 INR.
How to purchase Medicamen Biotech Limited stock?
You can buy MEDICAMEQ.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medicamen Biotech Limited?
The stock symbol or ticker of Medicamen Biotech Limited is MEDICAMEQ.NS.
Which industry does the Medicamen Biotech Limited company belong to?
The Medicamen Biotech Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Medicamen Biotech Limited have in circulation?
The max supply of Medicamen Biotech Limited shares is 12.71M.
What is Medicamen Biotech Limited Price to Earnings Ratio (PE Ratio)?
Medicamen Biotech Limited PE Ratio is 47.57458500 now.
What was Medicamen Biotech Limited earnings per share over the trailing 12 months (TTM)?
Medicamen Biotech Limited EPS is 9.05 INR over the trailing 12 months.
Which sector does the Medicamen Biotech Limited company belong to?
The Medicamen Biotech Limited sector is Healthcare.